Perfil
Greg DeFilippis worked as a Vice President-Business Development & Alliances at Antares Pharma, Inc. from 2013 to 2019.
Prior to that, he was a Director-Business Development at Teva Pharmaceuticals USA, Inc. Mr. DeFilippis holds an MBA degree from Fairleigh Dickinson University and an undergraduate degree from Virginia Polytechnic Institute & State University.
Antiguos cargos conocidos de Greg DeFilippis.
| Empresas | Cargo | Fin |
|---|---|---|
| ANTARES PHARMA, INC. | Corporate Officer/Principal | 01/12/2019 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Formación de Greg DeFilippis.
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Greg DeFilippis
